Skip to main content

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

NDC 70010-189 · Granules Pharmaceuticals Inc.

Generic nameLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE
Strength25; 100 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

70010-189-03 — 30 TABLET, FILM COATED in 1 BOTTLE (70010-189-03)

70010-189-10 — 1000 TABLET, FILM COATED in 1 BOTTLE (70010-189-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69097-972 — Fosinopril Sodium and Hydrochlorothiazide, 69097-973 — Fosinopril Sodium and Hydrochlorothiazide, 69315-130 — HYDROCHLOROTHIAZIDE, 69315-131 — HYDROCHLOROTHIAZIDE, 69315-155 — HYDROCHLOROTHIAZIDE, 69367-219 — Hydrochlorothiazide, 69584-361 — Hydrochlorothiazide, 69584-362 — Hydrochlorothiazide, 70010-187 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 70010-188 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 70010-741 — Losartan, 70010-742 — Losartan, 70010-743 — Losartan, 70436-014 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-015 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-016 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-017 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70436-018 — olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, 70518-0174 — Lisinopril and Hydrochlorothiazide, 70518-0196 — Lisinopril and Hydrochlorothiazide, +1060 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels